Environmental Risk Factors for Copy Number Variation in Human Chromosomes
人类染色体拷贝数变异的环境风险因素
基本信息
- 批准号:7817619
- 负责人:
- 金额:$ 48.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-28 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAphidicolinAreaAttentionAutistic DisorderBiological ModelsBleomycinCatalogingCatalogsCategoriesCell Culture TechniquesCell divisionCellsChromosomal RearrangementChromosome BreakageChromosomesCleft PalateComplexCongenital AbnormalityCongenital Heart DefectsCopy Number PolymorphismCoupledDNADNA DamageDNA Double Strand BreakDNA RepairDNA Sequence RearrangementDNA biosynthesisDataData SetDetectionDevelopmentDiseaseDoseEnvironmental ExposureEnvironmental Risk FactorEpilepsyEventEvolutionExperimental ModelsExposure toFloxuridineFolateFolic Acid AntagonistsFrequenciesGenesGeneticGenetic RecombinationGenetic VariationGenomeGenomicsGoalsHereditary DiseaseHumanHuman ChromosomesHuman GenomeIn VitroIndividualIonizing radiationKnowledgeLeadLymphoidMalignant NeoplasmsMediatingMeiosisMental RetardationMental disordersMethodsMicroscopeMicroscopicMitoticModelingMonitorMutateMutationNatureNormal CellPaperParentsPartner in relationshipPatternPlayPopulationPositioning AttributePreventionProcessPublishingRecoveryRecurrenceRecurrent diseaseResearchResearch PersonnelResolutionRibonucleotide Reductase InhibitorRiskRisk FactorsRoleSchizophreniaStagingStressStructureSystemTechniquesTechnologyTerminal Repeat SequencesTestingTimeVariantbasecancer cellchromosome replicationcomparativecostdevelopmental diseaseeggenvironmental agentgenetic risk factorgenome-widehomologous recombinationhuman diseasehydroxyureain vitro Modelin vivoinsightinterestnext generationnovelsperm cellstructural genomicstool
项目摘要
DESCRIPTION (provided by applicant):
This application addresses broad Challenge Area, (08) Genomics and Specific Challenge Topic, 08-ES-106: The role of environmental exposure in copy number variation (CNV): "Microscopic deletions and replications of the genome have attracted increasing attention for their potential role in many complex human diseases. Of particular interest are spontaneous CNVs, defined as those present in an affected individual, but absent in both parents. There is limited understanding of how spontaneous CNVs arise. Studies are needed that will determine whether environmental exposures can affect risk for copy number variation and other structural variations that have been implicated in complex diseases. Given the early stage of this research area, studies should focus on changes in cells exposed in vitro". In recent years, copy number variants (CNVs) have been found to be widely distributed throughout the human genome where they represent an important component of genetic variation and play an integral role in phenotypic diversity, complex disease and evolution. Over 1300 CNVs with frequencies of >1% have been described in healthy individuals that exist as deletions or duplications ranging in size from a few Kb to over a Mb, and this number will surely increase as more data become available. Similar spontaneous CNVs are now well known to be a major cause of genetic and developmental disorders, including mental retardation, autism, schizophrenia, epilepsy, cleft palate and many others. Studies of idiopathic mental retardation and developmental disorders have found de novo CNVs in 5-17% of affected individuals, suggesting a high mutation rate. Similar copy number alterations are also found at high frequency in many cancers where a role in initiation or progression is likely. CNVs are thus a key factor in normal genetic variation and evolution and are a very important class of mutation in genetic and developmental disorders and cancer. There is very limited understanding of how CNVs arise, the cellular mechanisms and risk factors that are involved, and the effects of environmental agents on their formation. As with all mutation classes, it is almost certain that environmental insults can induce or increase the risk for new and deleterious CNVs, however we have little knowledge of the mechanisms and frequency of such events. Meiotic unequal recombination [or non-allelic homologous recombination (NAHR)] mediated by flanking repeated sequences or segmental duplications leads to many recurrent, disease-related CNVs. However, there is growing evidence that many or most normal and sporadic, nonrecurrent CNVs, which account for the majority of disease-associated CNVs in humans and those in cancers arise via mechanisms coupled to aberrant DNA replication and/or non-homologous repair of DNA damage. This suggests an unexpected mitotic, rather than meiotic, cell origin for many CNVs and has a number of important implications for the role of environmental exposures in their formation and the development of in vitro model systems for their study. The Challenge, and our goal, is to determine the role of environmental factors in the formation of CNVs and to gain novel insight into the mechanisms by which these frequent mutations are generated. We have assembled a strong team of investigators and have developed a normal human cell culture model system coupled with leading edge genome analysis technologies, placing us in a unique position to address this timely Challenge. Using this system we have found that aphidicolin-induced replication stress leads to a remarkably high frequency of de novo CNVs. These findings lead us to hypothesize that environmentally-induced replication stress and/or DNA double strand breaks are two major factors leading to CNVs during mitotic cell divisions in the human germline and in cancer cells. To test this hypothesis, we will characterize environmental agent-induced CNVs at the genome-wide scale and directly compare the strength of these two non-exclusive models for CNV formation, thus providing for the first time a high resolution catalog of genomic manifestations of two different categories of environmental agents most likely to be associated with CNV formation. These are (1) agents that lead to replication stress, which might lead to CNVs through secondary breakage or replicative template switching, and (2) agents that directly induce DNA double-strand breaks (DNA DSBs), which might lead to CNVs through inappropriate joining of broken ends. Specifically, we will examine hydroxyurea and folate stress, which inhibit replication through different mechanisms than aphidicolin, and on ionizing radiation and bleomycin, which lead directly to DNA DSBs. Our "shovel ready" in vitro model system coupled with high resolution genomic microarrays and next-generation sequencing will allow us to determine the effects of these agents on the frequency, spectrum, distribution and structure of CNVs and other submicroscopic structural variations. The combined results will address a major gap in our knowledge about a very important class of mutations and allow predictions of the environmental agents that confer the greatest risk for ongoing structural alteration of the human genome.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS W GLOVER其他文献
THOMAS W GLOVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS W GLOVER', 18)}}的其他基金
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 48.56万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9336863 - 财政年份:2016
- 资助金额:
$ 48.56万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9173540 - 财政年份:2016
- 资助金额:
$ 48.56万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9756149 - 财政年份:2016
- 资助金额:
$ 48.56万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8775671 - 财政年份:2012
- 资助金额:
$ 48.56万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8219623 - 财政年份:2012
- 资助金额:
$ 48.56万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8415873 - 财政年份:2012
- 资助金额:
$ 48.56万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8578098 - 财政年份:2012
- 资助金额:
$ 48.56万 - 项目类别:
Environmental Risk Factors for Copy Number Variation in Human Chromosomes
人类染色体拷贝数变异的环境风险因素
- 批准号:
7941810 - 财政年份:2009
- 资助金额:
$ 48.56万 - 项目类别:
FOXC2 in Hereditary Lymphedema and Lymphatic Development
FOXC2 在遗传性淋巴水肿和淋巴管发育中的作用
- 批准号:
6896853 - 财政年份:2002
- 资助金额:
$ 48.56万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.56万 - 项目类别:
Research Grant